Metacrine, Inc.
NEWS
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The first week of November was marked by numerous clinical trial announcements. Here’s a look.
It was yet another busy week for clinical trial news. Here’s a look.
It was a busy week for biopharma, biotech and medical device initial public offerings (IPOs). Here’s a look.
Biopharma and life science companies from across the globe strengthen their leadership teams and boards with these Movers & Shakers.
Placebo-controlled, multi-center trial will evaluate safety, tolerability and efficacy biomarkers to assess potential best-in-class FXR agonist
Although the weekend was filled with news out of the American Society of Clinical Oncology Annual Meeting, here’s a roundup of some of the top clinical trial news from earlier last week.
The Baltimore Longitudinal Study of Aging was launched in 1958 by the National Institutes of Health. The idea was to follow and study the lives of healthy, active people over their lifetimes, rather than after they were dead.
Let’s take a look at who made a splash in the pharma and biotech world the past week.
JOBS
IN THE PRESS